SHE:002262 Market Cap

SHE:002262 has a market cap or net worth of 24.07 billion as of February 23, 2026. Its market cap has increased by 4.64% in one year.

Market Cap

24.07B

Enterprise Value

20.13B

Revenue

6.02B

Ranking

n/a

PE Ratio

19.58

Stock Price

23.70

Market Cap Chart

Since July 23, 2008, SHE:002262's market cap has increased from 1.26B to 24.07B, an increase of 1,803.85%. That is a compound annual growth rate of 18.26%.

Market Cap History

Date	Market Cap	% Change
Feb 13, 2026	24.07B	-1.78%
Dec 31, 2025	24.51B	-0.94%
Dec 31, 2024	24.74B	-9.45%
Dec 29, 2023	27.33B	10.47%
Dec 30, 2022	24.74B	56.87%
Dec 31, 2021	15.77B	-2.01%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Livzon Pharmaceutical Group	28.22B
Chengdu Kanghong Pharmaceutical Group	26.42B
Kangmei Pharmaceutical	26.14B
Hubei Jumpcan Pharmaceutical	25.04B
Dizal (Jiangsu) Pharmaceutical	25.02B
Zhejiang Huahai Pharmaceutical	23.41B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	22.80B
Tasly Pharmaceutical Group	21.92B

Market Cap Rankings